AVBP
ArriVent BioPharma, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$31.02
−0.03%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+1.7%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 22, 2026 | Nolet Chris · director | A-Award | 13,562 | $32 |
| Jun 22, 2026 | Hohneker John · director | A-Award | 13,562 | $32 |
| Jun 22, 2026 | Peterson Kristine · director | A-Award | 13,562 | $32 |
| Jun 22, 2026 | Parsey Merdad · director | A-Award | 13,562 | $32 |
| Feb 4, 2026 | Kastenmayer James Paul · officer: General Counsel | A-Award | 130,000 | $23 |
| Feb 4, 2026 | LaChapelle Robin · officer: Chief Operating Officer | A-Award | 130,000 | $23 |
| Feb 4, 2026 | Lutzker Stuart · director, officer: President of R&D | A-Award | 150,000 | $23 |
| Feb 4, 2026 | Kung Winston · officer: Chief Financial Officer | A-Award | 140,000 | $23 |
| Feb 4, 2026 | Yao Zhengbin · director, officer: President and CEO | A-Award | 550,000 | $23 |
| Feb 3, 2026 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. · 10 percent owner | Sale | 555,555 | $23 |
| Jul 15, 2025 | LaChapelle Robin · officer: Chief Operating Officer | M-Exempt | 6,503 | $2.28 |
| Jul 15, 2025 | LaChapelle Robin · officer: Chief Operating Officer | M-Exempt | 2,600 | $2.28 |
| Jul 15, 2025 | LaChapelle Robin · officer: Chief Operating Officer | M-Exempt | 2,050 | $2.28 |
| Jun 20, 2025 | Parsey Merdad · director | A-Award | 15,502 | $25 |
| Jun 20, 2025 | Peterson Kristine · director | A-Award | 15,502 | $25 |
| Jun 20, 2025 | Hohneker John · director | A-Award | 15,502 | $25 |
| Jun 20, 2025 | Nolet Chris · director | A-Award | 15,502 | $25 |
| Apr 29, 2025 | Parsey Merdad · director | A-Award | 28,346 | $21 |
| Feb 1, 2024 | HILLHOUSE INVESTMENT MANAGEMENT, LTD. · 10 percent owner | Purchase | 555,555 | $18 |
| Jan 31, 2024 | HEALY JAMES · director | Purchase | 444,444 | $18 |
| Jan 31, 2024 | GORDON CARL L · director, 10 percent owner: | Purchase | 222,222 | $18 |
| Jan 31, 2024 | ORBIMED ADVISORS LLC · director, 10 percent owner: | Purchase | 222,222 | $18 |
| Jan 29, 2024 | Nolet Chris · director | A-Award | 17,884 | $18 |
Institutional positioning
13F filings over the trailing two quarters
New 73Increased 133Reduced 59Sold out 15
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 4,515,531 | Aug 14, 2026 |
| INFINITUM ASSET MANAGEMENT, LLC | Increased | 4,438,384 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 4,401,083 | May 15, 2026 |
| INFINITUM ASSET MANAGEMENT, LLC | Increased | 4,148,923 | May 15, 2026 |
| HHLR ADVISORS, LTD. | Unchanged | 3,929,117 | Aug 14, 2026 |
| HHLR ADVISORS, LTD. | Unchanged | 3,929,117 | May 15, 2026 |
| BlackRock, Inc. | Increased | 3,250,396 | Aug 7, 2026 |
| ORBIMED ADVISORS LLC | Unchanged | 3,027,328 | Aug 14, 2026 |
| ORBIMED ADVISORS LLC | Unchanged | 3,027,328 | May 15, 2026 |
| FMR LLC | Reduced | 3,016,132 | May 15, 2026 |
| FMR LLC | Reduced | 2,778,959 | Aug 13, 2026 |
| BLACKROCK, INC. | Increased | 2,530,301 | May 13, 2026 |
| OCTAGON CAPITAL ADVISORS LP | Unchanged | 1,971,054 | May 15, 2026 |
| Octagon Capital Advisors LP | Unchanged | 1,971,054 | Aug 14, 2026 |
| NOVO HOLDINGS A/S | Unchanged | 1,942,142 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 22, 2026